Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Diabetes Mellitus: Type 2 and Gestational

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...

Type II Diabetes II: Pathophysiology

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.

Type II Diabetes I: Introduction

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...

Type I Diabetes II: Pathophysiology

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...

Carbohydrate Metabolism

Carbohydrate Metabolism

Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in the...

Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis

Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis

Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

CGM-derived average glucose is more strongly associated with microvascular complications than HbA1c in type 1 diabetes.

Diabetes, obesity & metabolism·2025

Same author

Commonly used C-peptide assays show differing associations with CGM metrics.

Diabetes, obesity & metabolism·2025

Same author

Modelling maternal cardiovascular adaptation to pregnancy: a scoping review.

BMC pregnancy and childbirth·2025

Same author

The use of machine learning to predict pharmacological therapy in gestational diabetes: A scoping review.

Diabetic medicine : a journal of the British Diabetic Association·2025

Same author

Preterm birth, socioeconomic status, and white matter development across childhood.

Developmental cognitive neuroscience·2025

Same author

Importance of targeting post-prandial hyperglycaemia to achieve HbA1c goals in insulin glargine-treated subphenotypes of type 2 diabetes.

Diabetes, obesity & metabolism·2025

Search research articles

Related Experiment Video

Updated: Jun 27, 2026

Osmotic Minipump Implantation for Increasing Glucose Concentration in Mouse Cerebrospinal Fluid

Osmotic Minipump Implantation for Increasing Glucose Concentration in Mouse Cerebrospinal Fluid

Published on: April 7, 2023

The relationship between type 2 diabetes and dementia.

Mark W J Strachan¹, Rebecca M Reynolds, Brian M Frier

¹Metabolic Unit, Western General Hospital, Crewe Road, Edinburgh EH42XU, UK. mark.strachan@luht.scot.nhs.uk

British Medical Bulletin

|November 26, 2008

Summary

Type 2 diabetes increases dementia risk, including Alzheimer's and vascular dementia. Further research is needed to understand the complex mechanisms and develop targeted interventions for diabetes-related cognitive impairment.

Related Experiment Videos

Last Updated: Jun 27, 2026

Osmotic Minipump Implantation for Increasing Glucose Concentration in Mouse Cerebrospinal Fluid

Osmotic Minipump Implantation for Increasing Glucose Concentration in Mouse Cerebrospinal Fluid

Published on: April 7, 2023

Area of Science:

Neurology
Endocrinology
Geriatrics

Background:

The global prevalence of type 2 diabetes and dementia is projected to increase significantly in the coming decades.
Growing evidence indicates a strong association between type 2 diabetes and an elevated risk of developing dementia.

Purpose of the Study:

To review the current understanding of the link between type 2 diabetes and dementia.
To explore the potential mechanisms and future research directions in this area.

Main Methods:

A narrative review approach was employed, synthesizing data from existing individual studies and review articles.
A comprehensive Medline search and review of reference lists were conducted to identify relevant literature.

Main Results:

Type 2 diabetes is linked to an increased risk of Alzheimer's disease and vascular dementia, often presenting as mixed dementia forms.
The precise mechanisms driving this association are not fully understood, likely involving multiple interacting factors due to the complexity of type 2 diabetes.

Conclusions:

Emerging evidence suggests that excess glucocorticoids and elevated inflammatory markers may contribute to cognitive impairment in individuals with diabetes.
Large-scale prospective studies and clinical trials incorporating cognitive outcomes are essential to elucidate the pathogenesis and inform interventions for diabetes-related cognitive decline.